Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 13641-1-AP - Provider product page

- Provider
- Proteintech Group
- Product name
- COMP antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated COMP antibody (Cat. #13641-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Interfering with UBE2L3 expression targets regulation of MLKL to promote necroptosis inhibition of growth in osteosarcoma.
Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway.
Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart.
Zhao X, Shan G, Xing D, Gao H, Xiong Z, Hui W, Gong M
World journal of surgical oncology 2025 Feb 24;23(1):63
World journal of surgical oncology 2025 Feb 24;23(1):63
Aspirin inhibits inflammation and scar formation in the injury tendon healing through regulating JNK/STAT-3 signalling pathway.
Wang Y, He G, Tang H, Shi Y, Kang X, Lyu J, Zhu M, Zhou M, Yang M, Mu M, Chen W, Zhou B, Zhang J, Tang K
Cell proliferation 2019 Jul;52(4):e12650
Cell proliferation 2019 Jul;52(4):e12650
Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability.
Schips TG, Vanhoutte D, Vo A, Correll RN, Brody MJ, Khalil H, Karch J, Tjondrokoesoemo A, Sargent MA, Maillet M, Ross RS, Molkentin JD
Nature communications 2019 Jan 8;10(1):76
Nature communications 2019 Jan 8;10(1):76
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart.
Fu X, Khalil H, Kanisicak O, Boyer JG, Vagnozzi RJ, Maliken BD, Sargent MA, Prasad V, Valiente-Alandi I, Blaxall BC, Molkentin JD
The Journal of clinical investigation 2018 May 1;128(5):2127-2143
The Journal of clinical investigation 2018 May 1;128(5):2127-2143
No comments: Submit comment
No validations: Submit validation data